EssilorLuxottica company profile
Company profile
EssilorLuxottica has 213,909 employees and is headquartered in Paris, France.
Ray-Ban and Oakley sunglasses, Essilor and Varilux lenses, and the Stellest and Transitions lines are the names most people associate with EssilorLuxottica, a Paris-based group that designs, manufactures and distributes ophthalmic lenses, frames, sunglasses and eyecare instruments. Its brands also include Persol, Oliver Peoples, Costa, Nikon and Foster Grant eyewear, as well as SPECTRALIS and ANTERION imaging platforms and Satisloh finishing equipment. Products reach independent opticians, distributors, large retail chains, third-party e-commerce platforms and consumers through brick-and-mortar stores and online channels in North America, the Middle East, Africa, Europe, Latin America and Asia-Pacific.
In the fiscal year ended December 2025, revenue reached EUR 28.5 billion, up 7.5% from the previous year, and net profit was EUR 2.3 billion. The group had 213,909 employees and is headquartered in Paris, France. It was founded in 1849 and took its current name in October 2018, when it was known as Essilor International Société Anonyme.
Company facts
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- France
- Headquarters
- 1-5 rue Paul Cézanne, 75008, Paris
- Employees
- 213,909
- Chief executive
- Francesco Milleri
- Founded
- 1849
- Fiscal year
- January - December
- Listing
- EL · Euronext Paris
- Indices
- CAC 40
- Currency
- EUR
- ISIN
- FR0000121667
- Website
- essilorluxottica.com
EssilorLuxottica and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| EssilorLuxotticaEL | France | $92.93B | 213,909 | 12.8% | 34.5 |
| AlconALC | Switzerland | $35.37B | 25,000 | 12.9% | 56.8 |
| Sartorius Stedim BiotechDIM | France | $23.87B | 10,483 | 19.2% | 67.0 |
| Straumann HoldingSTMN | Switzerland | $20.65B | 11,582 | 24.7% | 47.1 |
| SartoriusSRT | Germany | $17.15B | 14,273 | 17.8% | 72.2 |
| ColoplastCOLO.B | Denmark | $16.83B | 17,270 | 25.7% | 37.2 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
